Study of the Safety and Efficacy of OMS906 in Patients With Paroxysmal Nocturnal Hemoglobinuria
Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, pharmacokinetics,
pharmacodynamics, and preliminary efficacy in patients with Paroxysmal Nocturnal
Hemoglobinuria (PNH).